Stockreport

Verastem Oncology Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

Verastem, Inc.  (VSTM) 
Last verastem, inc. earnings: 10/29 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: verastem.com
PDF Achieved AVMAPKI™ FAKZYNJA™ CO-PACK net product revenue of $11.2 millionVS-7375 cleared first two monotherapy dose levels with no dose-limiting toxicities reported; no n [Read more]